GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Walvax Biotechnology Co Ltd (SZSE:300142) » Definitions » Cyclically Adjusted Price-to-FCF

Walvax Biotechnology Co (SZSE:300142) Cyclically Adjusted Price-to-FCF : (As of May. 28, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Walvax Biotechnology Co Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Walvax Biotechnology Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Walvax Biotechnology Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Walvax Biotechnology Co Cyclically Adjusted Price-to-FCF Chart

Walvax Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Walvax Biotechnology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Walvax Biotechnology Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Walvax Biotechnology Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Walvax Biotechnology Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Walvax Biotechnology Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Walvax Biotechnology Co's Cyclically Adjusted Price-to-FCF falls into.



Walvax Biotechnology Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Walvax Biotechnology Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Walvax Biotechnology Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.143/115.2271*115.2271
=-0.143

Current CPI (Mar. 2024) = 115.2271.

Walvax Biotechnology Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.009 98.200 -0.011
201409 -0.018 98.900 -0.021
201412 -0.040 99.000 -0.047
201503 -0.050 99.900 -0.058
201506 -0.097 99.500 -0.112
201509 -0.048 100.500 -0.055
201512 -0.056 100.600 -0.064
201603 -0.114 102.200 -0.129
201606 -0.097 101.400 -0.110
201609 -0.071 102.400 -0.080
201612 0.031 102.600 0.035
201703 -0.085 103.200 -0.095
201706 -0.064 103.100 -0.072
201709 -0.027 104.100 -0.030
201712 -0.055 104.500 -0.061
201803 -0.068 105.300 -0.074
201806 -0.037 104.900 -0.041
201809 -0.040 106.600 -0.043
201812 -0.046 106.500 -0.050
201903 -0.050 107.700 -0.053
201906 -0.077 107.700 -0.082
201909 0.016 109.800 0.017
201912 -0.077 111.200 -0.080
202003 -0.085 112.300 -0.087
202006 -0.050 110.400 -0.052
202009 0.034 111.700 0.035
202012 -0.087 111.500 -0.090
202103 -0.185 112.662 -0.189
202106 -0.095 111.769 -0.098
202109 -0.052 112.215 -0.053
202112 0.078 113.108 0.079
202203 -0.096 114.335 -0.097
202206 0.017 114.558 0.017
202209 0.107 115.339 0.107
202212 0.044 115.116 0.044
202303 -0.029 115.116 -0.029
202306 -0.020 114.558 -0.020
202309 0.136 115.339 0.136
202312 0.030 114.781 0.030
202403 -0.143 115.227 -0.143

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Walvax Biotechnology Co  (SZSE:300142) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Walvax Biotechnology Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Walvax Biotechnology Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Walvax Biotechnology Co (SZSE:300142) Business Description

Traded in Other Exchanges
N/A
Address
Keyuan Road No. 99, 19th Floor, Building 9A, Dingyi Tiancheng Residential Quarter, High & New Tech Development Zone, Yunnan Province, Kunming, CHN, 650106
Walvax Biotechnology Co Ltd biological pharmaceutical enterprise engaged in research and development, production and sales of bio-medicine products. It offers bio-medicines, such as vaccines, blood products, and others. The company's products include Haemophilus influenza type b conjugate vaccines, freeze-dried group A, C meningococcal polysaccharide conjugate vaccines, group ACYW135 meningococcal polysaccharide vaccines, and group A and C meningococcal polysaccharide vaccines.
Executives
Wu Yun Yan Executives
Zhao Jin Long Executives
Yao Wei Executives
Zhou Hua Executives
Shi Jing Executives
Jiang Run Sheng Directors, executives
Gong Sun Qing Executives
Executives
Yuan Lin Executives
Fang Guo Liang Executives
Li Yun Chun Director
Huang Zhen Director
Zhang Li Secretary Dong
Yang Hong Wei Supervisors
Xu Ke Ren Executives

Walvax Biotechnology Co (SZSE:300142) Headlines

No Headlines